Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Wellysis and Artella Solutions Launch Innovative Remote Cardiac Monitoring Service in the US. 2024-03-08 22:00
TransThera Announced Global Phase 3 Clinical Trial for Cholangiocarcinoma Authorized in the European Union and Orphan Drug Designation for Tinengotinib to Treat Biliary Tract Cancer Granted by European Medicines Agency 2024-03-08 21:00
"AXA Women's Health Centre" officially unveils on International Women's Day 2024-03-08 19:49
Advancing Healthcare Access: Genesis MedTech Teams Up with Silk Road Medical to Serve Patients affected by Carotid Artery Disease in China 2024-03-08 10:00
VISEN Announces Acceptance of a Biologics License Application for Lonapegsomatropin in China 2024-03-08 10:00
Uniting for Women's Wellness on IWD - From China to Uzbekistan 2024-03-08 08:07
Chime Biologics Achieves ISO 27001 Certification to Strengthen Information Security in the CDMO Industry 2024-03-07 22:00
Zylox-Tonbridge and Avinger Forge Strategic Partnership to Expand Disruptive OCT Solutions for Peripheral Vascular Interventions 2024-03-07 15:04
Innovent released the results of two clinical studies of IBI311 (an anti-IGF-1R monoclonal antibody) in oral presentations at the Asia-Pacific Academy of Ophthalmology Congress and International Congress of Endocrinology 2024 2024-03-07 11:53
Luye Pharma's Innovative Drug Zepzelca® (Lurbinectedin) Launched in Hong Kong and Macao 2024-03-07 10:11
A Global Milestone in Innovative Pancreatic Cancer Therapy 2024-03-07 10:00
Epitomee® announces the filing of a novel Weight Loss Capsule for FDA clearance 2024-03-07 09:00
OnCusp Therapeutics Announces First Patient Dosed in Phase 1 Trial of CUSP06 in Patients with Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors 2024-03-06 21:00
APAX Medical Introduces Cutting-Edge ADVATx Laser For Skin Rejuvenation 2024-03-06 20:22
Latest Updates of Viva Biotech's Portfolio Companies 2024-03-06 19:33
American, Finnish and Canadian governments fund oxygen plant at Tatu City SEZ, Kenya 2024-03-06 18:48
Akeso Announced the First Patient Dosed in Phase III Trial of Cadonilimab(PD-1/CTLA-4) Combined with Chemotherapy versus Tislelizumab Combined with Chemotherapy in First-line Treatment of PD-L1 negative NSCLC 2024-03-06 18:07
Innovative Visionary Mark W. Womack Strengthens Bridgewest Perth Pharma Pty Ltd Board, Amplifying NovaCina's Growth Vision 2024-03-06 12:29
AACR 2024 | Ascentage Pharma to Present Three Preclinical Studies at 2024 American Association of Cancer Research Annual Meeting 2024-03-06 08:59
Everest Medicines to Announce Full-Year 2023 Financial Results on March 28, 2024 2024-03-06 08:59
1 89 90 91 92 93 962